| Indicator | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue | ¥978.7B | ¥952.9B | +2.7% |
| Operating Income | ¥27.8B | ¥35.7B | -22.1% |
| Equity-Method Investment Income (Loss) | - | - | - |
| Ordinary Income | ¥24.8B | ¥38.3B | -35.4% |
| Net Income | ¥17.5B | ¥28.0B | -37.5% |
| ROE | 5.2% | 8.6% | - |
FY2026 Q2 results: Revenue ¥978.7B (YoY +¥25.8B +2.7%), Operating Income ¥27.8B (YoY -¥7.9B -22.1%), Ordinary Income ¥24.8B (YoY -¥13.5B -35.4%), Net Income ¥17.5B (YoY -¥10.5B -37.5%). Growth in revenue with profit decline. Revenue increased for the second consecutive period while profitability fell materially versus the prior year. Gross profit margin was 6.3%, down 50bps from 6.8% a year earlier. SG&A amounted to ¥34.2B (prior ¥29.2B), up +17.2%, and SG&A ratio rose to 3.5% (prior 3.1%). Operating margin deteriorated to 2.8% (prior 3.7%), and Ordinary Income margin declined to 2.5% (prior 4.0%), indicating broad deterioration in profitability. An increase in inventories of ¥66.4B led Operating Cash Flow to -¥22.4B, well below Net Income, and Free Cash Flow was -¥44.7B, reflecting weakened cash generation.
【Revenue】 Revenue ¥978.7B, up ¥25.8B (+2.7%) YoY. The company operates a single Food Business segment with segment breakdown undisclosed. Cost of sales was ¥916.6B (up ¥27.9B +3.1%), rising faster than revenue growth, pushing gross margin down to 6.3% from 6.8% a year earlier (50bps decline). The primary drivers of gross margin compression are estimated to be higher procurement costs with delayed pass-through to selling prices, and/or a deterioration in selling-price mix due to changes in product mix. Foreign exchange gains of ¥1.1B were recorded while FX losses of ¥0.8B also occurred, indicating FX volatility may have impacted both revenue and profit.
【Profitability】 Gross profit was ¥62.0B (prior ¥64.9B, -¥2.9B). SG&A was ¥34.2B, up ¥5.0B (+17.2%) from prior ¥29.2B, raising the SG&A ratio to 3.5% (prior 3.1%). Details of the SG&A increase are undisclosed but suggest higher logistics, labor, and system-related fixed costs. As a result, Operating Income was ¥27.8B (down ¥7.9B -22.1%), with an operating margin of 2.8% (prior 3.7%). Non-operating income fell to ¥2.0B (prior ¥7.2B) while non-operating expenses rose slightly to ¥5.1B (prior ¥4.6B), yielding non-operating items of -¥3.1B (prior +¥2.6B), a deterioration of ¥5.7B. Major non-operating expenses were interest expense ¥3.4B (prior ¥2.3B) and fees ¥1.2B (prior ¥1.1B), reflecting higher interest-bearing debt and rising interest rates. Ordinary Income was ¥24.8B (down ¥13.5B -35.4%), with an ordinary margin of 2.5% (prior 4.0%). After corporate taxes of ¥7.3B (effective tax rate 29.3%), Net Income was ¥17.5B (down ¥10.5B -37.5%), and net margin declined to 1.8% (prior 2.9%). Overall, the company posted revenue growth but earnings decline, driven by lower gross margins, higher SG&A ratio, and deterioration in non-operating results, which amplified the decline at the ordinary-income level.
【Profitability】Operating margin 2.8% declined 0.9pt from 3.7% a year earlier; net margin 1.8% declined 1.1pt from 2.9%, indicating broad deterioration in profitability. The 50bps decline in gross margin to 6.3% and SG&A ratio increase to 3.5% (prior 3.1%) were the main drivers of margin compression. ROE fell sharply to 5.2% (prior 8.6%), reflecting lower net margin and depressed capital efficiency. 【Cash Quality】Operating Cash Flow -¥22.4B versus Net Income ¥17.5B yields OCF/Net Income of -1.28x, indicating weak cash generation. The main cause was an inventory increase of ¥66.4B, with working capital expansion absorbing cash. Operating CF subtotal (before working capital changes) was -¥10.9B, ¥28.4B below Net Income ¥17.5B, showing the scale of non-cash items cannot be covered by depreciation ¥2.3B alone. 【Investment Efficiency】Total asset turnover declined to 0.98x (prior 1.06x), with inventory expansion to ¥507.7B (50.6% of total assets) depressing asset efficiency. Days Inventory Outstanding (DIO) is estimated at about 210 days, indicating inventory stagnation. 【Financial Soundness】Equity Ratio declined to 33.3% (prior 36.0%), D/E rose to 2.01x (prior 1.78x), increasing financial leverage. Current ratio 161.9% (prior 170.4%) remains healthy, but quick ratio 71.4% (prior 79.8%) indicates high inventory dependence. Interest-bearing debt totaled ¥381.1B (prior ¥341.0B) comprising short-term borrowings ¥223.9B, CP ¥60B, and long-term borrowings ¥97.2B, up +11.8% YoY. Short-term debt ratio is high at 69.7%, implying refinancing risk from maturity mismatch. Interest coverage is approximately 8.2x (Operating Income ¥27.8B ÷ Interest Expense ¥3.4B), showing short-term interest payment capacity, but interest expense rose by ¥1.1B from prior ¥2.3B, indicating rising interest burden.
Operating CF was -¥22.4B (prior -¥78.5B), an improvement of ¥56.1B YoY, but still negative and well below Net Income ¥17.5B. The main cause was inventory increase of -¥66.4B, which consumed cash in working capital. Accounts payable increase of +¥26.6B and decrease in accounts receivable +¥3.8B partially offset but did not fully mitigate inventory growth. Operating CF subtotal (before working capital changes) was -¥10.9B, ¥28.4B below Net Income ¥17.5B, indicating a gap not explainable by depreciation ¥2.3B alone. Investing CF was -¥22.3B, driven by capital expenditures -¥19.0B and intangible asset acquisitions -¥2.96B. Tangible fixed assets increased to ¥56.1B (prior ¥35.5B), +58.2%, and intangible fixed assets to ¥10.6B (prior ¥7.5B), +40.5%, indicating ongoing growth investment. Free Cash Flow was -¥44.7B (Operating CF -¥22.4B + Investing CF -¥22.3B), a large negative, which was funded by Financing CF inflows of +¥58.3B. Financing CF composition: long-term borrowings +¥53.1B, net increase in short-term borrowings +¥1.5B, dividend payments -¥8.2B, etc., resulting in cash and deposits at period-end ¥116.5B (opening ¥101.6B), up +¥14.9B. Weak cash conversion is evident; inventory reduction and normalization of working capital in H2 are key to stabilizing liquidity.
Operating Income ¥27.8B versus Ordinary Income ¥24.8B shows non-operating items contributed -¥3.1B. The main non-operating expense was interest expense ¥3.4B, up ¥1.1B from ¥2.3B, reflecting higher interest-bearing debt and rising rates. Fees of ¥1.2B are also recorded as recurring non-operating costs. Non-operating income totaled ¥2.0B (FX gains ¥1.1B, interest income ¥0.3B, etc.), a large decline from ¥7.2B a year earlier, suggesting volatility from FX or one-off items previously. The difference between Ordinary Income ¥24.8B and Net Income ¥17.5B is taxes of ¥7.3B (effective tax rate 29.3%); no extraordinary items were recorded, so ordinary-stage earnings translated directly to net profit. Operating CF -¥22.4B vs Net Income ¥17.5B gives OCF/Net Income -1.28x, indicating accruals moved materially negative. The principal cause is inventory increase ¥66.4B, widening the timing gap between revenue recognition and cash collection. Accounts receivable were ¥23.7B (prior ¥23.9B), little changed, so deteriorating cash quality is primarily due to inventory stagnation. While recurring profitability is stable at the ordinary level, working capital management issues have relatively lowered earnings quality, and attention should be paid to inventory reduction and improving accounts payable balance in H2.
Full Year plan unchanged: Revenue ¥1,930.0B (YoY +5.6%), Ordinary Income ¥48.0B (YoY -17.2%), Net Income ¥34.5B. No revision at the end of Q2. Cumulative results to Q2 represent Revenue ¥978.7B (50.7% of full-year plan), Ordinary Income ¥24.8B (51.6%), Net Income ¥17.5B (50.6%), roughly 50% progress and near linear. However, Q2 standalone operating margin was low at 2.8%, so full-year margin recovery depends on gross margin improvement and SG&A control in H2. Normalization of inventory level ¥507.7B (prior ¥442.8B, +14.7%) will significantly affect H2 cash flow and margins; inventory reduction and price pass-through are key to hitting full-year targets. The company has not revised guidance and presumably expects a H2 recovery, but given linear progress and Q2 margin deterioration, the extent of H2 improvement will be critical.
Interim dividend is ¥66 per share. Based on average shares outstanding during the period of 9,991 thousand shares, total dividend payout is approximately ¥0.66B. Dividend payout ratio versus Net Income ¥17.5B is approximately 37.9%, a reasonable level. Full-year dividend forecast remains ¥66 per share, an increase from prior-year actual annual ¥50, indicating a dividend raise. Free Cash Flow, however, is -¥44.7B, yielding FCF coverage of -6.74x, so dividends are being financed through financing activities rather than operating cash flow. Cash and deposits ¥116.5B (11.6% of total assets) and retained earnings ¥269.3B (prior ¥260.0B) indicate some capacity for dividends, but given working capital expansion and short-term debt ratio of 69.7%, dividend sustainability depends on H2 inventory reduction and OCF improvement. No share buybacks were executed; shareholder returns are composed solely of dividends. Based on full-year plan EPS ¥345.01 and DPS ¥66, the payout ratio is about 19.1%, a conservative level, and while there may be room for further increases depending on H2 performance, a cautious stance is warranted given the current cash flow structure.
Working capital expansion risk: Inventory ¥507.7B (50.6% of total assets) increased ¥64.9B YoY (+14.7%), with DIO lengthening to about 210 days. There is risk of inventory write-downs and liquidity pressure. Since inventory increase -¥66.4B is the main cause of Operating CF -¥22.4B, if inventory reduction does not progress in H2, full-year Free Cash Flow may remain substantially negative and reliance on financing activities could become entrenched. Inventory composition is undisclosed, but given the Food Business nature, risks from shelf-life and deterioration exist, raising concerns about markdowns in volatile market conditions.
Financial leverage and interest rate risk: Interest-bearing debt ¥381.1B (prior ¥341.0B, +11.8%) with D/E 2.01x and short-term debt ratio 69.7% indicates high leverage and short-term concentration. Interest expense ¥3.4B, up ¥1.1B (+47.8%) from prior, highlights profit compression risk in a rising-rate environment. Although interest coverage of 8.2x shows short-term capacity, with operating margin at a low 2.8%, tolerance for further interest cost increases is limited. Including refinancing risk, sensitivity to interest-rate changes on earnings and balance sheet is high.
Structural risk of declining profitability: A drop in gross margin to 6.3% (prior 6.8%) and rise in SG&A ratio to 3.5% (prior 3.1%) reduced operating margin to 2.8% (prior 3.7%). SG&A growth +17.2% far outpaced revenue growth +2.7%, suggesting rising fixed-cost burden. Causes may include delayed price pass-through, adverse product mix, and cost inflation in logistics and labor. If price revisions do not take hold or cost pressures persist in H2, operating margin may remain depressed and full-year targets risk non-achievement.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 2.8% | – | – |
| Net Margin | 1.8% | 7.0% (6.4%–7.5%) | -5.2pt |
The company’s net margin 1.8% is 5.2pt below the industry median 7.0%, placing profitability in the lower tier of the industry.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | 2.7% | 4.5% (2.2%–5.8%) | -1.7pt |
Revenue growth 2.7% trails the industry median 4.5% by 1.7pt, indicating top-line expansion is somewhat below peers.
※ Source: Company compilation
Feasibility of inventory reduction and cash normalization: Reducing inventories of ¥507.7B (50.6% of total assets, DIO ~210 days) and freeing working capital is the top priority for H2. To narrow Operating CF -¥22.4B and Free CF -¥44.7B, improvement in inventory turnover and optimization of accounts payable are essential. Monthly inventory trends and reversal of Operating CF from Q3 onward will determine full-year performance and financial health.
Gross margin recovery and progress of pricing policy: Decline in gross margin to 6.3% (prior 6.8%, -50bps) is a key driver of compressed operating margin 2.8%. H2 progress in price revisions, product mix improvements, and stabilization of procurement costs will be critical for margin recovery. Controlling the rise in SG&A ratio to 3.5% (prior 3.1%) is also required; effective fixed-cost management will be tested. The final full-year operating margin will be an indicator of structural resilience in the revenue model.
Monitoring financial leverage and interest-rate sensitivity: With D/E 2.01x, short-term debt ratio 69.7%, and interest expense up 47.8%, changes in the interest-rate environment and borrowing conditions are important. Monitor H2 refinancing plans, reassessment of short/long-term balance, and maintenance of interest coverage. Without operating margin improvement, rising interest costs could exert downward pressure on both ROE and dividend capacity.
This report was auto-generated by AI analyzing XBRL financial statement data and is intended as an earnings analysis document. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company based on public financial statements. Investment decisions are your responsibility; please consult a specialist as necessary before acting.